DK4039688T3 - Substitueret pyrrolopyrimidin og pyrazolopyrimidin som brutons tyrosinkinase- (btk) nedbrydere - Google Patents
Substitueret pyrrolopyrimidin og pyrazolopyrimidin som brutons tyrosinkinase- (btk) nedbrydere Download PDFInfo
- Publication number
- DK4039688T3 DK4039688T3 DK22154786.2T DK22154786T DK4039688T3 DK 4039688 T3 DK4039688 T3 DK 4039688T3 DK 22154786 T DK22154786 T DK 22154786T DK 4039688 T3 DK4039688 T3 DK 4039688T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrasolopyrimidine
- bruton
- btk
- inhibitors
- tyrosine kinase
- Prior art date
Links
- 102000001714 Agammaglobulinaemia Tyrosine Kinase Human genes 0.000 title 2
- 108010029445 Agammaglobulinaemia Tyrosine Kinase Proteins 0.000 title 2
- 239000003112 inhibitor Substances 0.000 title 1
- 150000004944 pyrrolopyrimidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163145126P | 2021-02-03 | 2021-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4039688T3 true DK4039688T3 (da) | 2025-01-02 |
Family
ID=80447078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK22154786.2T DK4039688T3 (da) | 2021-02-03 | 2022-02-02 | Substitueret pyrrolopyrimidin og pyrazolopyrimidin som brutons tyrosinkinase- (btk) nedbrydere |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20240132502A1 (da) |
| EP (2) | EP4039688B1 (da) |
| JP (1) | JP2024505558A (da) |
| KR (1) | KR20230142539A (da) |
| CN (1) | CN117042769A (da) |
| CA (1) | CA3209082A1 (da) |
| DK (1) | DK4039688T3 (da) |
| ES (1) | ES3010513T3 (da) |
| FI (1) | FI4039688T3 (da) |
| MX (1) | MX2023008865A (da) |
| WO (1) | WO2022169798A2 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI809489B (zh) * | 2020-09-10 | 2023-07-21 | 美商絡速藥業公司 | 用於製備(s)-5-胺基-3-(4-((5-氟-2-甲氧基苯甲醯胺基)甲基)苯基)-1-(1,1,1-三氟丙烷-2-基)-1h-吡唑-4-甲醯胺之方法及中間體 |
| EP4452945A2 (en) * | 2021-12-20 | 2024-10-30 | Sigma-Aldrich Co. LLC | Chemical linkers |
| CN118515673A (zh) * | 2023-02-17 | 2024-08-20 | 江苏威凯尔医药科技有限公司 | Btk抑制剂及其用途 |
| CN120051475A (zh) * | 2023-05-26 | 2025-05-27 | 广东弘烨医药科技有限公司 | 9元杂芳基化合物、含其的药物组合物及其制备方法和应用 |
| WO2025024521A1 (en) | 2023-07-25 | 2025-01-30 | Monte Rosa Therapeutics, Inc. | Substituted piperidinediones for targeted protein degradation |
| CN120535526A (zh) * | 2024-02-26 | 2025-08-26 | 中国药科大学 | 直接结合蛋白酶体的非泛素依赖型蛋白水解靶向嵌合体NuTAC及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114946A (en) | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
| US4818541A (en) | 1987-08-19 | 1989-04-04 | Schering Corporation | Transdermal delivery of enantiomers of phenylpropanolamine |
| CN105017256A (zh) * | 2014-04-29 | 2015-11-04 | 浙江导明医药科技有限公司 | 多氟化合物作为布鲁顿酪氨酸激酶抑制剂 |
| CN106146511A (zh) * | 2015-04-03 | 2016-11-23 | 安润医药科技（苏州）有限公司 | 吡唑并嘧啶衍生物、制备方法、药物组合物及用途 |
| HK1258779A1 (zh) * | 2015-09-16 | 2019-11-22 | Loxo Oncology Inc. | 用於治療癌症的作為btk抑制劑的吡唑並嘧啶衍生物 |
| US10399988B2 (en) * | 2016-07-07 | 2019-09-03 | Daewoong Pharmaceutical Co., Ltd. | 4-aminopyrazolo[3,4-d]pyrimidinylazabicyclo derivatives and pharmaceutical composition comprising the same |
| TW201811795A (zh) * | 2016-08-24 | 2018-04-01 | 美商亞闊股份有限公司 | 胺基－吡咯并嘧啶酮化合物及其用途 |
| WO2019177902A1 (en) * | 2018-03-10 | 2019-09-19 | Yale University | Modulators of btk proteolysis and methods of use |
| WO2020023851A1 (en) * | 2018-07-26 | 2020-01-30 | Yale University | Bifunctional substitued pyrimidines as modulators of fak proteolyse |
| CA3133004A1 (en) * | 2019-05-31 | 2020-12-03 | Sichuan Haisco Pharmaceutical Co., Ltd. | Btk inhibitor ring derivative, preparation method therefor and pharmaceutical application thereof |
| WO2020252397A1 (en) * | 2019-06-12 | 2020-12-17 | Baylor College Of Medicine | Small molecule proteolysis-targeting chimeras and methods of use thereof |
| CN112812100B (zh) * | 2019-11-18 | 2022-04-05 | 四川海思科制药有限公司 | 一种具有降解btk激酶的化合物及其制备方法和药学上的应用 |
| CN112979656A (zh) * | 2019-12-12 | 2021-06-18 | 上海美志医药科技有限公司 | 一类靶向降解btk蛋白的化合物 |
-
2022
- 2022-02-02 DK DK22154786.2T patent/DK4039688T3/da active
- 2022-02-02 US US18/263,656 patent/US20240132502A1/en active Pending
- 2022-02-02 EP EP22154786.2A patent/EP4039688B1/en active Active
- 2022-02-02 CN CN202280022626.5A patent/CN117042769A/zh active Pending
- 2022-02-02 EP EP24204895.7A patent/EP4501327A3/en active Pending
- 2022-02-02 JP JP2023546433A patent/JP2024505558A/ja active Pending
- 2022-02-02 CA CA3209082A patent/CA3209082A1/en active Pending
- 2022-02-02 KR KR1020237029298A patent/KR20230142539A/ko active Pending
- 2022-02-02 ES ES22154786T patent/ES3010513T3/es active Active
- 2022-02-02 WO PCT/US2022/014830 patent/WO2022169798A2/en not_active Ceased
- 2022-02-02 MX MX2023008865A patent/MX2023008865A/es unknown
- 2022-02-02 US US17/591,051 patent/US11530222B2/en active Active
- 2022-02-02 FI FIEP22154786.2T patent/FI4039688T3/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4039688B1 (en) | 2024-10-09 |
| CN117042769A (zh) | 2023-11-10 |
| EP4501327A3 (en) | 2025-10-15 |
| JP2024505558A (ja) | 2024-02-06 |
| EP4501327A2 (en) | 2025-02-05 |
| EP4039688A2 (en) | 2022-08-10 |
| US20240132502A1 (en) | 2024-04-25 |
| US20220259207A1 (en) | 2022-08-18 |
| US11530222B2 (en) | 2022-12-20 |
| WO2022169798A3 (en) | 2022-09-22 |
| MX2023008865A (es) | 2023-08-31 |
| FI4039688T3 (fi) | 2024-12-19 |
| WO2022169798A2 (en) | 2022-08-11 |
| KR20230142539A (ko) | 2023-10-11 |
| EP4039688A3 (en) | 2022-11-23 |
| CA3209082A1 (en) | 2022-08-11 |
| ES3010513T3 (en) | 2025-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK4039688T3 (da) | Substitueret pyrrolopyrimidin og pyrazolopyrimidin som brutons tyrosinkinase- (btk) nedbrydere | |
| ECSP22083904A (es) | Compuestos, composiciones farmacéuticas y métodos para la preparación de compuestos y para su uso | |
| SA522432225B1 (ar) | Cdk2 أمينات ثنائية الحلقة كمثبطات | |
| ECSP21038390A (es) | Compuestos, composiciones farmacéuticas y métodos de preparación de compuestos y de su uso como inhibidores de la cinasa atr | |
| BR112022007612A2 (pt) | Inibidores de raf quinases | |
| NO20072567L (no) | Triazoler nyttige som proteinkinase-inhibitorer | |
| DE60332433D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
| DK1791830T3 (da) | Diaminotriazol-forbindelser der er nyttige som protein-kinase-inhibitorer | |
| NO20081893L (no) | 4-(3-aminopyrazol)pyrimidinderivater til anvendelse som tyrosin-kinaseinhibitorer i behandling av kreft | |
| DE60314603D1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
| ATE468336T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
| BRPI0606313A2 (pt) | derivados de 4-(1h-indol-3-il)-pirimidin-2-ilamina, processo para sua preparação e seu uso em terapia | |
| NO331166B1 (no) | Inhibitorer av tyrosinkinaser, fremgangsmate for fremstilling derav, farmasoytisk preparat samt anvendelse av forbindelsene | |
| NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
| EE200300475A (et) | Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis | |
| AR031152A1 (es) | Tratamientos nuevos para el sindrome de piernas inquietas | |
| NO20070334L (no) | 4,6-disubstituerte pyrimidiner og deres anvendelse som proteinkinaseinhibitorer | |
| IL287745A (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| CR8255A (es) | Tienopirazoles | |
| MX2021013602A (es) | Inhibidores de jak. | |
| LT3972604T (lt) | Brutono tirozino kinazės inhibitorius, skirtas naudoti lėtinės spontaninės dilgėlinės gydymui | |
| CO2024009144A2 (es) | Inhibidores de cinasa met | |
| ATE411279T1 (de) | Arylsulfonamidobenzylverbindungen | |
| ATE435858T1 (de) | Prodrugs von als erk-proteinkinase-inhibitoren wirkenden pyrrolylpyrimidinen | |
| BR112017024633A2 (pt) | novo amidoeteroaril aroil hidrazida etino |